Chronic GnRH agonist administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment
- 1 May 1996
- journal article
- research article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 125 (2), 141-145
- https://doi.org/10.1007/bf02249413
Abstract
The effect of pretreatment with the gonadotropin releasing hormone (GnRH) agonistd-Trp6-LHRH (Decapeptyl) on platelet serotonin transporter in women undergoing assisted reproductive treatment (ART) was investigated and compared with women treated with human menopausal gonadotropin (Pergonal). The study group (n=10) was exposed for 12 days to 3.2 mg Decapeptyl C.R. while a comparison group (n=9) was exposed to 11 days of human meno-pausal gonadotropin (Pergonal). All patients were assessed with the Hamilton depression and anxiety scales before and after treatment, and platelet and plasma samples were collected at the same time points. Plasma levels of estradiol, progesterone, FSH and LH were determined by radioimmunoassay (RIA). Platelet serotonin transporter was labeled using high affinity [3H]imipramine binding. The GnRH analogue induced ovarian suppression as reflected by low plasma estradiol levels, while Pergonal administration induced ovarian stimulation. An elevation in the Hamilton depression and anxiety scale scores was observed in the Decapeptyl treated group; this mood alteration was associated with a significant decrease (19%,Pmax) of platelet [3H]imipramine binding sites. No significant change was observed in the Bmax of the Pergonal treated group. These results indicate that ovarian suppression (menopausal-like state) in young women is associated with depressed and anxious mood and decreased serotonin transporter density.Keywords
This publication has 19 references indexed in Scilit:
- Induced Anovulation As Treatment Of Premenstrual Tension Syndrome: A double‐blind cross‐over study with GnRH‐agonist versus placeboActa Obstetricia et Gynecologica Scandinavica, 1988
- THE USE OF AN LHRH AGONIST, BUSERELIN, IN THE LONG-TERM MANAGEMENT OF PREMENSTRUAL SYNDROMESClinical Endocrinology, 1987
- Therapeutic Uses of Gonadotropin-Releasing Hormone AnalogsObstetrical & Gynecological Survey, 1987
- The Premenstrual SyndromeNew England Journal of Medicine, 1984
- Serotonergic and noradrenergic receptors in the rat brain: Modulation by chronic exposure to ovarian hormonesLife Sciences, 1983
- LHRH and rat avoidance behavior: Influence of castration and testosteronePhysiology & Behavior, 1983
- Demonstration of specific high affinity binding sites for [3H] imipramine in human brainLife Sciences, 1980
- Demonstration of specific “high affinity” binding sites for [3H] imipramine on human plateletsLife Sciences, 1980
- EFFECT OF GONADOTROPIN-RELEASING HORMONE ON DEPRESSED MOODThe Lancet, 1979
- Luteinizing Hormone-Releasing Factor Potentiates Lordosis Behavior in Hypophysectomized Ovariectomized Female RatsScience, 1973